Replies to post #557760 on NorthWest Biotherapeutics Inc (NWBO)

[no2koolaid]

bio, great post and I am actually happy you misapprehended my position.

Due to a single degree of separation, I used a common contact to get some time with a couple of senior executives at CRL before the great pandemic. The bulk of their business is CRO work and manufacturing is less than 20% of its business, with CDMO a relatively new business. So, I checked their last annual report to confirm and here it is...

Our Cell and Gene Therapy CDMO business made great progress during its
first year as part of the Charles River family, and the business continues to
gain traction on business development activities to support its robust growth potential. With the additions of Cognate and Vigene

To your point about the Reddit crowd, CRL could not afford NWBO and does not compete in that industry; a point beyond the grasp of some.